The median time to disease recognition for the two groups also showed a difference, but again this did not reach statistical significance (median time to CAO 189 (IQR 93–275) days vs 619 (IQR 182–819) days for those with and without endobronchial disease, respectively (p=0.09)).
← all excerpts
Prevalence and outcome of central airway obstruction in patients with lung cancer.
1
0.0900
0.0900